These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
168 related items for PubMed ID: 7566488
1. Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity. Bresink I, Danysz W, Parsons CG, Mutschler E. Neuropharmacology; 1995 May; 34(5):533-40. PubMed ID: 7566488 [Abstract] [Full Text] [Related]
2. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain. Mugnaini M, van Amsterdam FT, Ratti E, Trist DG, Bowery NG. Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727 [Abstract] [Full Text] [Related]
3. Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds. Nankai M, Klarica M, Fage D, Carter C. Neurochem Int; 1996 Nov; 29(5):529-42. PubMed ID: 8939463 [Abstract] [Full Text] [Related]
4. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes. Wong EH, Knight AR, Woodruff GN. J Neurochem; 1988 Jan; 50(1):274-81. PubMed ID: 2826686 [Abstract] [Full Text] [Related]
5. Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo. Parsons CG, Quack G, Bresink I, Baran L, Przegalinski E, Kostowski W, Krzascik P, Hartmann S, Danysz W. Neuropharmacology; 1995 Oct; 34(10):1239-58. PubMed ID: 8570022 [Abstract] [Full Text] [Related]
6. Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration. Cory-Slechta DA, Garcia-Osuna M, Greenamyre JT. Behav Brain Res; 1997 May; 85(2):161-74. PubMed ID: 9105573 [Abstract] [Full Text] [Related]
7. Regional variations in the pharmacology of NMDA receptor channel blockers: implications for therapeutic potential. Porter RH, Greenamyre JT. J Neurochem; 1995 Feb; 64(2):614-23. PubMed ID: 7530291 [Abstract] [Full Text] [Related]
9. Pharmacological characterization of the N-methyl-D-aspartate (NMDA) receptor-channel in rodent and dog brain and rat spinal cord using [3H]MK-801 binding. Sharif NA, Nunes JL, Whiting RL. Neurochem Res; 1991 May; 16(5):563-9. PubMed ID: 1836546 [Abstract] [Full Text] [Related]
10. Identification of a novel NMDA receptor in rat cerebellum. Ebert B, Wong EH, Krogsgaard-Larsen P. Eur J Pharmacol; 1991 Sep 12; 208(1):49-52. PubMed ID: 1682157 [Abstract] [Full Text] [Related]
12. Characterization of the non-competitive antagonist binding site of the NMDA receptor in dark Agouti rats. Sun W, Wessinger WD. Life Sci; 2004 Aug 06; 75(12):1405-15. PubMed ID: 15240177 [Abstract] [Full Text] [Related]
17. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. Yoneda Y, Ogita K. J Pharmacol Exp Ther; 1991 Oct 06; 259(1):86-96. PubMed ID: 1681092 [Abstract] [Full Text] [Related]
18. Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study. Kornhuber J, Bormann J, Hübers M, Rusche K, Riederer P. Eur J Pharmacol; 1991 Apr 25; 206(4):297-300. PubMed ID: 1717296 [Abstract] [Full Text] [Related]
19. The pharmacological specificity of N-methyl-D-aspartate receptors in rat cerebral cortex: correspondence between radioligand binding and electrophysiological measurements. Grimwood S, Foster AC, Kemp JA. Br J Pharmacol; 1991 Jun 25; 103(2):1385-92. PubMed ID: 1832067 [Abstract] [Full Text] [Related]